Monoclonal Antibodies May Stop Vertical HIV Transmission From Mom to Baby

Introducción Two monoclonal antibodies appeared safe and tolerable when administered alone or in combination to newborns exposed to HIV, according to a proof-of-concept study presented at the International AIDS Society Conference on HIV Science in Kigali, Rwanda. Over 28 days of safety observation, infants who received either or both antibodies CAP256V2LS or VRC07-523LS experienced only […]

Drowning Prevention Is a Team Effort, Pediatricians Say

Drowning remains the leading cause of deathopens in a new tab or window among 1- to 4-year-olds, and a multi-layered approach to prevention is necessary, according to a new policy statementopens in a new tab or window from the American Academy of Pediatrics (AAP). Those methods include functional barriers, effective supervision, water competence, and early […]

Children’s Hospital Ordered to Resume Gender-Affirming Care for Minors

Resumen del Caso The Colorado Supreme Court has ordered Colorado’s largest provider of gender-affirming care for young people to resume medical treatments like puberty blockers and hormone therapy despite threats that providing the care could lead to losing federal funding. Children’s Hospital Colorado suspended medical treatments for transgender patients under 18 in January after it […]

No Infants Developed Measles After Utah Prophylaxis Regimen

Introducción After 11 infants were exposed to measles at a pediatric clinic in Utah, the state Department of Health and Human Services (DHHS) helped administer intramuscular immunoglobulin (IMIG) as postexposure prophylaxis (PEP) and ultimately developed a protocol for statewide use amid the ongoing outbreak. None of the infants’ parents declined IMIG for their child, and […]

ACP urges reform as Medicare Advantage broker payments at $10 billion

Clinical Takeaway: Patients increasingly choose Medicare Advantage plans with help from brokers paid by insurers, a dynamic that may steer enrollment toward higher-commission plans rather than the best clinical fit. Clinicians can ask older patients how they selected their plan and whether their preferred specialists and medications are covered. Medicare Advantage now enrolls more than […]

Vanessa Trump’s Cancer; 3 Deaths Tied to Mystery Substance; Ebola Clinic Torched

Note that some links may require registration or subscription. Also note that MedPage Today will be closed Monday in observance of Memorial Day. Look for Morning Break again on Tuesday, May 26. Vanessa Trump, 48, the former wife of Donald Trump Jr., announced she has breast canceropens in a new tab or window. (People) Two-time […]

GLP-1s Linked to Lower Risk of Cancer Spread in Four Tumor Types

CHICAGO — Use of GLP-1 receptor agonists in patients with four solid tumor types was significantly associated with lower rates of progression to metastatic disease over a 5-year period, a propensity score-matched analysis found. In patients with stage I-III colorectal, liver, breast, or lung cancers, those who started a GLP-1 drug after their cancer diagnosis […]

AI mammogram risk scores outperform existing breast cancer tools

Clinical Takeaway: Image-derived AI risk scores may improve identification of women who’d benefit from prevention or closer screening. Broader validation is needed before clinical adoption. Current breast cancer risk models rely on lifestyle and family history rather than the mammogram itself and were largely built from White cohorts that limit performance in non-European populations. Two […]

Screening beyond family history: Early testing detects most future type 1 diabetes cases

Clinical Takeaway: Population-based screening for early-stage type 1 diabetes in children appears feasible in routine pediatric practice and identifies most children who later develop clinical disease. The findings support broader screening strategies beyond family-history–based testing and may help facilitate earlier intervention and use of emerging disease-modifying therapies. Identificación temprana Type 1 diabetes can begin years […]

Drug Sheds 28% of Weight; Universal T1D Screening? Lilly Accuses Church of Fraud

Pérdida de peso con retatrutide Patients with obesity dropped a mean 28% of their body weight with a 12-mg dose of the investigational triple-receptor agonist retatrutide over 80 weeks in a phase III study, Eli Lilly announced. Nearly half had weight loss of 30% or greater, levels typically only seen with bariatric surgery. Beneficio limitado […]

Cargando